ArticleEpilepsia2026
Transcriptional signatures and topological reorganization of morphometric similarity networks in temporal lobe epilepsy with unilateral hippocampal sclerosis.
Article in Epilepsia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
objectiveTo delineate morphometric similarity network (MSN) topological abnormalities and their underlying spatial transcriptomics in the normal-appearing cortex of unilateral mesial temporal lobe epilepsy with hippocampal sclerosis (mTLE-HS).
methodsHigh-resolution T1-weighted magnetic resonance imaging (MRI) from 109 unilateral mTLE-HS patients (64 left, 45 right) and 90 matched controls were analyzed to construct individual-level MSNs by integrating five cortical morphometric features. Graph-theoretical analysis quantified global and local network topology, and machine-learning models assessed their values in patient identification and epileptogenic lateralization, with performance further evaluated in an independent validation dataset. Further connectome-transcriptome association analyses linked these macroscale topological abnormalities to the microscale substrates in specific gene expressions, biological pathways, cellular compositions, and neurodevelopmental windows.
resultsPatients exhibited global small-worldness increase and local nodal reorganizations, with hyper-connectivity in default mode and limbic networks and hypo-connectivity in temporo-occipital cortex. These MSN-topology abnormalities enabled accurate patient classification (77.4%) and epileptogenic lateralization (83.2%), driven predominantly by features from limbic network (40.0% and 41.1%, respectively). These performances were reproducible in an independent validation dataset (classification accuracy = 75.4%, lateralization accuracy = 77.1%). Spatial transcriptomics mapped the MSN-topology alterations to expression of genes enriched in RNA processing and mitochondrial energy metabolism, including key epilepsy risk genes such as DNM1 and PPFIA3. These genes showed enriched expression in excitatory neurons, astrocytes, and oligodendrocytes, peaking during neurodevelopment in early-fetal striatum and neonatal-to-childhood cortex. SIGNIFICANCE: MSN topology delineates the pattern of cortical network reorganization in mTLE-HS, aiding in patient identification and lateralization. The convergence of these macroscale connectomic alterations with microscale transcriptomic profiles points to an RNA-metabolic interplay that shapes cortical vulnerability of mTLE-HS in a progressive way.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.